Thus, it has been shown that p53-like immunoreactivity is increased in PD-affected brains [195] and that p53 contributes to 6-hydroxydopamine-induced cell death, an experimental model of PD-like pathology [196,197,198]. The gene discussed is TP53; the disease is Parkinson disease.